Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionEukles Asset Management
Latest Disclosed Ownership1,221 shares
Latest Disclosed Value $ 170,101
Eukles Asset Management reports 1.85% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 5, 2026 - Eukles Asset Management filed a 13F-HR form disclosing ownership of 1,221 shares of Gilead Sciences, Inc. (CH:GILD) valued at $170,101 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 1,244 shares of Gilead Sciences, Inc.. This represents a change in shares of -1.85% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F Gilead Sciences Common Stock 375558103 1,221 -23 -1.85 170 11.84 0.0758
2026-02-09 2025-12-31 13F Gilead Sciences Common Stock 375558103 1,244 -12,172 -90.73 153 -89.79 0.0593
2025-11-05 2025-09-30 13F Gilead Sciences Common Stock 375558103 13,416 -168 -1.24 1,489 -1.13 0.5798
2025-08-06 2025-06-30 13F Gilead Sciences Common Stock 375558103 13,584 -326 -2.34 1,506 -3.34 0.6159
2025-04-29 2025-03-31 13F Gilead Sciences Common Stock 375558103 13,910 -116 -0.83 1,559 20.31 0.6839
2025-01-29 2024-12-31 13F Gilead Sciences Common Stock 375558103 14,026 -159 -1.12 1,296 8.92 0.5520
2024-10-29 2024-09-30 13F Gilead Sciences Common Stock 375558103 14,185 -251 -1.74 1,189 20.10 0.4774
2024-08-01 2024-06-30 13F Gilead Sciences Common Stock 375558103 14,436 -171 -1.17 990 -7.39 0.4286
2024-05-13 2024-03-31 13F GILEAD SCIENCES Common Stock 375558103 14,607 389 2.74 1,070 -7.12 0.4653
2024-01-31 2023-12-31 13F Gilead Sciences Common Stock 375558103 14,218 -469 -3.19 1,152 4.64 0.5446
2023-10-25 2023-09-30 13F Gilead Sciences Common Stock 375558103 14,687 85 0.58 1,101 -2.22 0.5812
2023-08-01 2023-06-30 13F Gilead Sciences Common Stock 375558103 14,602 64 0.44 1,125 -6.72 0.5754
2023-04-28 2023-03-31 13F Gilead Sciences Common Stock 375558103 14,538 -61 -0.42 1,206 120,500.00 0.6559
2023-01-27 2022-12-31 13F Gilead Sciences Common Stock 375558103 14,599 724 5.22 1 -99.88 0.7313
2022-10-28 2022-09-30 13F GILEAD SCIENCES Common Stock 375558103 13,875 298 2.19 856 2.03 0.5608
2022-07-28 2022-06-30 13F Gilead Sciences Common Stock 375558103 13,577 150 1.12 839 5.14 0.5311
2022-04-27 2022-03-31 13F Gilead Sciences Common Stock 375558103 13,427 -1,113 -7.65 798 -24.43 0.4339
2022-02-10 2021-12-31 13F Gilead Sciences Common Stock 375558103 14,540 -304 -2.05 1,056 1.83 0.5110
2021-10-28 2021-09-30 13F Gilead Sciences Common Stock 375558103 14,844 -41 -0.28 1,037 1.17 0.5674
2021-07-27 2021-06-30 13F Gilead Sciences Common Stock 375558103 14,885 790 5.60 1,025 12.51 0.5681
2021-04-27 2021-03-31 13F Gilead Sciences Common Stock 375558103 14,095 97 0.69 911 11.64 0.5891
2021-01-26 2020-12-31 13F GILEAD SCIENCES Common Stock 375558103 13,998 332 2.43 816 -5.56 0.5643
2020-10-29 2020-09-30 13F GILEAD SCIENCES Common 375558103 13,666 128 0.95 864 -17.00 0.6725
2020-07-29 2020-06-30 13F Gilead Sciences Common 375558103 13,538 895 7.08 1,041 10.16 0.8860
2020-04-22 2020-03-31 13F Gilead Sciences Common 375558103 12,643 -640 -4.82 945 9.50 0.9846
2020-01-24 2019-12-31 13F Gilead Sciences Common 375558103 13,283 -162 -1.20 863 1.29 0.7031
2019-10-29 2019-09-30 13F Gilead Sciences Common 375558103 13,445 -43 -0.32 852 -6.48 0.7381
2019-08-01 2019-06-30 13F GILEAD SCIENCES Common 375558103 13,488 -59 -0.44 911 3.41 0.7921
2019-04-23 2019-03-31 13F Gilead Sciences Common 375558103 13,547 67 0.50 881 4.51 0.8037
2019-01-22 2018-12-31 13F Gilead Sciences Common 375558103 13,480 13,480 843 0.8788
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.